8-K
filed December 18, 2025, 6:59 PM ET
ticker LONA
CIK 0001620463
M&A
confidence high
sentiment neutral
materiality 0.85
Athira Pharma raises ~$90M via PIPE and licenses lasofoxifene from Sermonix
LeonaBio, Inc.
- PIPE gross proceeds ~$90M; investors include Commodore, TCGX, Perceptive; priced at $6.35/share with warrants.
- Sermonix license grants exclusive rights to oral lasofoxifene outside Asia; $34.9M equity issued to Sermonix.
- Milestone payments to Sermonix up to $100M; royalties from sub-single to low-single digit percentages.
- Ligand agreement imposes separate milestones up to $21M and mid-single to low-double digit royalties.
- Commodore and TCGX each get board designee if holding ≥5%; Company to seek resignation of two current directors.
Key facts
Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
LeonaBio, Inc. issued 21,259,842 shares of Common Stock of warrant to a select group of investors, including Commodore Capital LP, TCG Crossover Management LLC, Perceptive Advisors and other accredited investors.
- Security
- warrant
- Shares
- 21,259,842 shares of Common Stock
- Purchaser
- a select group of investors, including Commodore Capital LP, TCG Crossover Management LLC, Perceptive Advisors and other accredited investors
Exact text from the filing
The PIPE Series B Common Warrants will have an exercise price of $7.62 per share payable on a cashless net exercise basis
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
LeonaBio, Inc. issued 5,356,547 shares of common stock to a select group of investors, including Commodore Capital LP, TCG Crossover Management LLC, Perceptive Advisors and other accredited investors for $6.35 per share.
- Security
- common stock
- Shares
- 5,356,547 shares
- Purchaser
- a select group of investors, including Commodore Capital LP, TCG Crossover Management LLC, Perceptive Advisors and other accredited investors
- Consideration
- $6.35 per share
Exact text from the filing
Shares, the “ PIPE Shares ”). The purchase price for each PIPE Initial Share (including the accompanying PIPE Series A Common Warrants and PIPE Series B Common Warrants) is $6.35 and the purchase price for each PIPE Pre-Funded Warrant (including the accompanying PIPE Series A Common Warrants and PIPE Series B Common Warrants) is $6.349 per each underlying
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
LeonaBio, Inc. issued 23,031,494 shares of Common Stock of warrant to a select group of investors, including Commodore Capital LP, TCG Crossover Management LLC, Perceptive Advisors and other accredited investors.
- Security
- warrant
- Shares
- 23,031,494 shares of Common Stock
- Purchaser
- a select group of investors, including Commodore Capital LP, TCG Crossover Management LLC, Perceptive Advisors and other accredited investors
Exact text from the filing
The PIPE Series A Common Warrants will have an exercise price of $6.35 per share
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
LeonaBio, Inc. issued 8,816,684 shares of Common Stock underlying pre-funded warrants of warrant to a select group of investors, including Commodore Capital LP, TCG Crossover Management LLC, Perceptive Advisors and other accredited investors for $6.349 per underlying share.
- Security
- warrant
- Shares
- 8,816,684 shares of Common Stock underlying pre-funded warrants
- Purchaser
- a select group of investors, including Commodore Capital LP, TCG Crossover Management LLC, Perceptive Advisors and other accredited investors
- Consideration
- $6.349 per underlying share
Exact text from the filing
Shares, the “ PIPE Shares ”). The purchase price for each PIPE Initial Share (including the accompanying PIPE Series A Common Warrants and PIPE Series B Common Warrants) is $6.35 and the purchase price for each PIPE Pre-Funded Warrant (including the accompanying PIPE Series A Common Warrants and PIPE Series B Common Warrants) is $6.349 per each underlying
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.